Success Story: NIW Approved Without RFE! We Helped a Chinese Staff Scientist Achieve Success
Client’s Testimonial:
"It has been a great pleasure to work with your team in the past 2 years.”
On May 7th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Staff Scientist in the Field of Biomedical Sciences (Approval Notice).
General Field: Biomedical Sciences
Position at the Time of Case Filing: Staff Scientist
Country of Origin: China
State of Residence at the Time of Filing: California
Approval Notice Date: May 7th, 2026
Processing Time: 21 months, 29 days
Case Summary:
We are pleased to share the success of an EB-2 NIW (National Interest Waiver) petition for a researcher in the field of biomedical sciences. The client, who holds a Ph.D. in Cell, Molecular and Developmental Biology, secured approval by demonstrating that their work possesses both substantial merit and national importance to the United States. North America Immigration Law Group (NAILG) successfully argued that the client’s contributions to advancing diagnostic capabilities for cardiovascular diseases and cancer are critical for improving public health outcomes.
The client’s proposed endeavor focuses on expanding the modern scientific understanding of RNA-mediated endothelium through the use of innovative high-throughput sequencing technologies, bioinformatics approaches, and multi-scale models. Currently employed as a staff scientist, the client investigates the mechanisms of endothelial dysfunction to aid in the early diagnosis and treatment of cardiovascular conditions associated with diabetes and cancer.
NAILG highlighted that this work aligns directly with U.S. national priorities to combat pervasive diseases. We demonstrated that the client’s research is supported by major funding sources, including the National Institutes of Health (NIH), the U.S. Department of Agriculture (USDA), the Chan Zuckerberg Initiative, and the National Natural Science Foundation of China (NSFC). We argued that this financial backing serves as objective validation of the client’s significance, as these funds are reserved for research that promotes health, agricultural advancements, and critical socioeconomic development.
To prove that the client is well-positioned to advance this endeavor, we presented a documented record of scholarly success. The client has authored 20 peer-reviewed journal articles (4 of them co-first-authored), 7 conference abstracts (2 of them first-authored), 1 book chapter, and 1 technical report.
While the client's publications have been cited a total of 1,160 times, NAILG did not present this raw metric as self-evidently sufficient. Instead, we provided a qualitative analysis using citation percentiles to demonstrate the high relative impact of the work. Additionally, the client's standing in the field is evidenced by their record of peer review service, having completed at least 5 reviews for authoritative, highly-ranked journals.
To further substantiate the client’s influence, NAILG submitted 2 letters of recommendation from independent experts in the field. These letters corroborated the client’s unique analytical skill set and the broad applicability of their multi-omics methodologies in advancing targeted therapies and precision medicine. By effectively framing the client’s credentials around the strategic importance of cardiovascular and cancer research, and validating their influence through high-level funding and citation percentiles, we built a persuasive case. The petition was approved, affirming the national significance of the client’s work in enhancing the quality and effectiveness of the U.S. healthcare system. We are proud to have assisted this dedicated scientist in securing their NIW approval.